BioCentury | Oct 24, 2016
Financial News

Nektar completes follow-on

...million Price: $13.50 Shares after offering: 149.7 million Underwriters: JPMorgan; Jefferies; Piper Jaffray; William Blair; Brean Capital...
BioCentury | Oct 19, 2016
Financial News

Nektar raises $175.5M in follow-on

...13 million shares at $13.50 in a follow-on underwritten by JPMorgan, Piper Jaffray, William Blair, Brean Capital...
BioCentury | Jun 27, 2016
Financial News

Scynexis completes follow-on

...Shares: 9.4 million Price: $2.40 Shares after offering: 23.3 million Underwriters: Guggenheim Securities; Canaccord; Needham; Brean Capital...
BioCentury | May 23, 2016
Strategy

Continental appetite

...Ariad wouldn't say when it expects data from the study. Novartis markets Gleevec and Tasigna. Brean Capital...
BioCentury | May 9, 2016
Financial News

Neuralstem completes follow-on

...million Shares: 20 million Price: $0.40 Shares after offering: 112 million Underwriters: Roth Capital Partners; Brean Capital...
BioCentury | Jan 11, 2016
Financial News

Akebia completes follow-on

...million Price: $9 Shares after offering: 37.9 million Underwriters: Morgan Stanley; UBS; JMP Securities; Needham; Brean Capital...
BioCentury | Jan 4, 2016
Analyst Picks & Changes

Analyst picks & changes

...9% for the week ended Dec. 24, when Butt issued his report. Chimerix Inc. (NASDAQ:CMRX) Brean Capital...
BioCentury | Nov 23, 2015
Financial News

Axsome Therapeutics completes IPO

...Shares: 5.7 million Price: $9 Shares after offering: 19.1 million Underwriters: Ladenburg Thalmann; Cantor Fitzgerald; Brean Capital...
BioCentury | Nov 20, 2015
Financial News

Axsome dips after $51M IPO

...5.7 million shares at $9 in an IPO underwritten by Ladenburg Thalmann, Cantor Fitzgerald and Brean Capital...
BioCentury | Nov 9, 2015
Financial News

Axsome Therapeutics amends IPO

...raised: Up to $55.3 million Shares: 4.3 million Price: $11-$13 Underwriters: Ladenburg Thalmann; Cantor Fitzgerald; Brean Capital...
...plans to sell 4.3 million shares at $11-$13. The company also added Cantor Fitzgerald and Brean Capital...
Items per page:
1 - 10 of 101
BioCentury | Oct 24, 2016
Financial News

Nektar completes follow-on

...million Price: $13.50 Shares after offering: 149.7 million Underwriters: JPMorgan; Jefferies; Piper Jaffray; William Blair; Brean Capital...
BioCentury | Oct 19, 2016
Financial News

Nektar raises $175.5M in follow-on

...13 million shares at $13.50 in a follow-on underwritten by JPMorgan, Piper Jaffray, William Blair, Brean Capital...
BioCentury | Jun 27, 2016
Financial News

Scynexis completes follow-on

...Shares: 9.4 million Price: $2.40 Shares after offering: 23.3 million Underwriters: Guggenheim Securities; Canaccord; Needham; Brean Capital...
BioCentury | May 23, 2016
Strategy

Continental appetite

...Ariad wouldn't say when it expects data from the study. Novartis markets Gleevec and Tasigna. Brean Capital...
BioCentury | May 9, 2016
Financial News

Neuralstem completes follow-on

...million Shares: 20 million Price: $0.40 Shares after offering: 112 million Underwriters: Roth Capital Partners; Brean Capital...
BioCentury | Jan 11, 2016
Financial News

Akebia completes follow-on

...million Price: $9 Shares after offering: 37.9 million Underwriters: Morgan Stanley; UBS; JMP Securities; Needham; Brean Capital...
BioCentury | Jan 4, 2016
Analyst Picks & Changes

Analyst picks & changes

...9% for the week ended Dec. 24, when Butt issued his report. Chimerix Inc. (NASDAQ:CMRX) Brean Capital...
BioCentury | Nov 23, 2015
Financial News

Axsome Therapeutics completes IPO

...Shares: 5.7 million Price: $9 Shares after offering: 19.1 million Underwriters: Ladenburg Thalmann; Cantor Fitzgerald; Brean Capital...
BioCentury | Nov 20, 2015
Financial News

Axsome dips after $51M IPO

...5.7 million shares at $9 in an IPO underwritten by Ladenburg Thalmann, Cantor Fitzgerald and Brean Capital...
BioCentury | Nov 9, 2015
Financial News

Axsome Therapeutics amends IPO

...raised: Up to $55.3 million Shares: 4.3 million Price: $11-$13 Underwriters: Ladenburg Thalmann; Cantor Fitzgerald; Brean Capital...
...plans to sell 4.3 million shares at $11-$13. The company also added Cantor Fitzgerald and Brean Capital...
Items per page:
1 - 10 of 101